STOK | Stoke Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Bedford, Massachusetts, United States Trade prices Volume: Market Cap: 539.64M Prev closed: Open: 24.62 High: 24.95 Low: 23.86 52 week low: 16.62 52 week high: 50.33 Dividends: No Dividends Next ER: May 9, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 9, 2023 March 6, 2023 -0.65 / -0.7133.27M / 2.86MBeat! November 14, 2022 -0.66 / -0.68432.91M / 2.72MBeat! August 8, 2022 -0.63 / -0.68763.23M / 2.64MBeat! May 10, 2022 -0.66 / 0.36193M / 50Mview more
Historical Data Date Price Open High Low Vol Change ER May 2, 2023 9.84 9.82 10.17
9.45
261K -0.3% May 1, 2023 9.87 9.35 10.24
9.35
225K 11.02% Apr 28, 2023 8.89 8.71 9.27
8.7
137K 1.72% Apr 27, 2023 8.74 9.01 9.07
8.73
114K -2.56% Apr 26, 2023 8.97 8.21 9.23
8.21
197K 10.60% Apr 25, 2023 8.11 8.15 8.54
8.01
307K 0.12% Apr 24, 2023 8.1 8.58 8.87
8.07
120K -6.68% Apr 21, 2023 8.68 8.51 8.78
8.47
125K 2% Apr 20, 2023 8.51 8.94 9.11
8.48
94.2K -5.55% Apr 19, 2023 9.01 8.61 9.19
8.56
276K 4.65% view more
NASDAQ - Nasdaq Stock Market
News
Stoke Therapeutics to Host Webinar and Conference Call to Present Interim Data from the Phase 1/2a Studies of STK-001 in Children and Adolescents with Dravet Syndrome finance.yahoo.com Dec 3, 2022 7:30 am
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates finance.yahoo.com Dec 3, 2022 7:00 am
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a MONARCH and ADMIRAL Studies of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2022 Annual Meeting finance.yahoo.com Dec 2, 2022 9:00 am Stoke Therapeutics drops 27% after early data for anti-seizure medicine seekingalpha.com Nov 15, 2022 1:40 am Stoke Therapeutics GAAP EPS of -$0.66 beats by $0.02, revenue of $2.91M beats by $0.19M seekingalpha.com Nov 14, 2022 9:31 pm
Stoke Therapeutics Stock Falls Post Early Efficacy Data From Lead Dravet Syndrome Program finance.yahoo.com Nov 14, 2022 1:02 pm
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates finance.yahoo.com Oct 25, 2022 7:30 am
Stoke Therapeutics to Participate in the Cowen 42nd Annual Health Care Conference finance.yahoo.com Oct 25, 2022 7:30 am
Stoke Therapeutics to Present at the 2022 Jefferies Healthcare Conference finance.yahoo.com Oct 25, 2022 7:30 am Stoke Therapeutics GAAP EPS of -$0.63 beats by $0.05, revenue of $3.2M beats by $0.18M seekingalpha.com Aug 8, 2022 8:40 pm Stoke Therapeutics GAAP EPS of -$0.66 misses by $0.04 seekingalpha.com Mar 10, 2022 8:48 pm Stoke Therapeutics initiated Buy at Jefferies on potential of RNA platform seekingalpha.com Feb 1, 2022 2:08 am RNA startup inks deal worth up to $967M bizjournals.com Jan 10, 2022 1:20 pm
Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases finance.yahoo.com Oct 25, 2022 7:00 am
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates finance.yahoo.com Oct 25, 2022 7:00 am
Stoke Therapeutics (NASDAQ:STOK) adds US$56m to market cap in the past 7 days, though investors from a year ago are still down 43% finance.yahoo.com Oct 19, 2022 10:02 am
We're Interested To See How Stoke Therapeutics (NASDAQ:STOK) Uses Its Cash Hoard To Grow finance.yahoo.com Aug 19, 2022 6:40 am
7 Stocks Due for a Stunning Short Squeeze finance.yahoo.com Aug 9, 2022 11:54 am Stoke Therapeutics GAAP EPS of -$0.66 misses by $0.98, revenue of $3M misses by $34.5M seekingalpha.com May 10, 2022 7:43 pm
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates finance.yahoo.com May 10, 2022 7:00 am This company doesn't provide a dividend.
Talk about Stoke Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
